BioWorld MedTech

March 26, 2014

Latin America: Lack of accredited importers main barrier to entering the Colombian market

A rapidly improving economy, more stable politics and incremental improvements in the regulatory environment are all conspiring to make Colombia one of the most sought after med-tech markets in Latin America. Read More

Report From Israel, Part 2 of 2: Weizmann Institute creates national center for personalized medicine

DermTech completes validation of its pigmented lesion assay

Washington Roundup: FDA hints clinical trials may be appropriate for special controls

Financings Roundup: Nephros completes rights offering, nets $2.14 million

Agreements/contracts: PatientPoint, HealthTronics provide health management

New Ventures: MedLumics intitates BiopsyPen Project with EUR3.6 milion from EU

Briefly Noted

Product briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Rare earth: Biomarin to use global reach post-$4.8B Amicus buy

BioWorld

Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...